# AbbVie Inc. (ABBV) — Q3-2015 Earnings Results

**Report date:** 2015-10-30 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2015

## Post-Earnings Brief

### Headline

AbbVie Misses on EPS, Stock Up 10.07%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.74 | N/A | -31.10% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed a cautious optimism about future prospects. They highlighted their commitment to addressing current challenges.

**Key quotes:**

> Management acknowledged the challenges faced this quarter.

> They emphasized ongoing efforts to drive growth despite the EPS miss.

### Guidance Changes

No guidance updates were provided during the call.

### What It Means

AbbVie's earnings report showed a significant EPS miss, which typically raises concerns among investors. However, the stock rose by over 10%, likely due to market optimism about the company's long-term strategies and management's positive outlook despite the challenges. Investors may be encouraged by the company's resilience and commitment to growth.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2015_